NVIDIA Corporation $NVDA Shares Sold by Aviance Capital Partners LLC

NVIDIA reported a strong quarter with $1.30 EPS versus $1.23 expected and revenue of $57.01 billion (up 62.5% YoY), delivering a 52.41% net margin and 101.74% ROE. Management announced a small quarterly dividend ($0.01; annualized $0.04) and set Q4 2026 EPS guidance, while analysts largely remain constructive (consensus price target $258.30 with multiple raises). Institutional positioning remains high (65.27% owned) amid notable portfolio moves and large insider sales (CEO sold 25,000 shares at $207.91; CFO sold 27,640 at $208.33; insiders sold 3,177,203 shares worth ~$570.2M last quarter), a mix that may temper near-term sentiment despite beat and upgraded analyst targets.

Analysis

Market structure: NVIDIA’s beat (Q rev $57B vs $54.7B est) confirms the company as the primary beneficiary of the AI data‑center capex cycle — winners include NVDA, TSM (TSM), key cloud buyers (AMZN, MSFT, GOOGL) and packaging suppliers; losers are incumbents with weaker AI GPU roadmaps (INTC, AMD) and any legacy CPU‑centric vendors. Pricing power is improving: >60% YoY revenue growth implies sustained ASP expansion and the potential for tight supply to keep gross margins elevated for 2–4 quarters.

Risk assessment: Tail risks include renewed US/China export controls (6–12 month event), a sudden TSMC capacity shock, or a hyperscaler pivot to custom silicon reducing NVDA demand; assign ~10–15% probability to a material China demand disruption in the next 12 months. Near term (days) expect earnings chop and IV compression; short term (weeks/months) monitor guidance and channel checks; long term (quarters/years) NVDA’s fate hinges on data‑center GPU replacement cycles and wafer capacity expansion.

Trade implications: Base case—construct a controlled long with downside protection: consider a 2–3% core long NVDA position sized to portfolio risk with a 10–15% stop; complement with 6–12 month call spreads (buy 200–300 Jan 2026 call spread) to cap cost and capture upside to $300+ if AI spending continues. Relative plays: long NVDA / short AMD or INTC as a 1:0.6 notional pair to monetize NVDA’s superior ASP/margin profile.

Contrarian angles: Consensus is heavily positive (consensus PT $258) and may underprice regulatory/export risk and hyperscaler self‑sourcing; insider sales (~$570M in quarter) could be tax/liquidity driven but raise caution on near‑term sentiment. If guidance softens or NVDA signals inventory build, the move down could be sharp — consider maintaining hedges until 1–2 post‑earnings data points confirm demand durability.

Key Decisions for Investors

• Establish a 2–3% portfolio long position in NVDA (buy up to $230) targeting 30–40% upside to $300–320 over 6–12 months; hard stop-loss at 12% below entry and trim 50% of position on a 20% rally.
• Implement a cost‑efficient bullish options spread: buy Jan 2026 NVDA 200C and sell Jan 2026 300C (ratio 1:1) sized to replace 50% of the delta exposure of the cash long — max risk = net premium, breakeven ~ strike + premium.
• Run a relative value pair: go long NVDA (1% notional) and short AMD (0.6% notional) to exploit margin/ASP dispersion; reassess if AMD widens gross margin by >200bps or NVDA guidance disappoints.
• Hedge macro/regulatory tail risk: purchase 3–6 month NVDA puts (e.g., buy one 180P for each $10k notional of NVDA exposure) if US/China export headlines escalate; unwind if no policy shift within 60 days.
• Monitor three triggers before scaling: (1) TSMC capacity announcements (wafer allocation increases by >10% signals ability to meet demand), (2) next quarterly guidance beat/miss (within 30–45 days), and (3) any new export control legislation — take action within 48 hours of such events.